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Abstract
Background: Dental pulp stem/stromal cells (DPSCs) are categorized as adult stem cells (ASCs) that retain
multipotent differentiation capabilities. DPSCs can be isolated from individuals at any age and are considered to be
true personal stem cells, making DPSCs one of the potential options for stem cell therapy. However, the properties
of DPSCs from individuals with an inherited genetic disorder, such as Huntington’s disease (HD), have not been
fully investigated.
Results: To examine if mutant huntingtin (htt) protein impacts DPSC properties, we have established DPSCs from
tooth germ of transgenic monkeys that expressed both mutant htt and green fluorescent protein (GFP) genes
(rHD/G-DPSCs), and from a monkey that expressed only the GFP gene (rG-DPSCs), which served as a control.
Although mutant htt and oligomeric htt aggregates were overtly present in rHD/G-DPSCs, all rHD/G-DPSCs and rG-
DPSCs shared similar characteristics, including self-renewal, multipotent differentiation capabilities, expression of
stemness and differentiation markers, and cell surface antigen profile.
Conclusions: Our results suggest that DPSCs from Huntington monkeys retain ASC properties. Thus DPSCs derived
from individuals with genetic disorders such as HD could be a potential source of personal stem cells for
therapeutic purposes.
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Background
DPSCs are ASCs and were first described in 2000 [1].
DPSCs share similar characteristics with bone marrow
derived mesenchymal stem/stromal cells (BMSCs) [1-4].
DPSCs have been differentiated into neuronal cells
under the guidance of neurogenic factors [5-10]. Addi-
tionally, DPSCs may also be therapeutic by providing
trophic support [4,11] or recruiting endogenous cells for
repair [4,12].
Most studies involving ASCs are derived from healthy
donors, and studies involving DPSCs have, in general,
been limited. Due to the advantages of using one’so w n
cells for therapy [13,14], plus their potential use in the
central nervous system (CNS) [4-9,15,16], we are inter-
ested in characterizing DPSCs derived from individuals
with HD and determined if HD-DPSCs retain compar-
able stem cell properties to those derived from a healthy
individual.
HD is a dominant genetic disorder caused by a muta-
tion resulting in the expansion of polyglutamine (CAG)
repeats in exon 1 of the IT15 gene encoding for htt.
CAG repeat lengths over 39 results in pathological HD.
A negative correlation has been shown between repeat
length and age of onset [17] and lifespan [18]. The hall-
mark of HD is neurodegeneration, predominantly in the
striatum and cortex [19]. Many HD patients do suffer
from tooth decay; however this decay is due to medica-
tion and lack of motor skills to perform teeth mainte-
nance procedures [20,21]. Here we have used transgenic
HD monkeys [22] as a model for investigating the effect
of mutant htt on the properties of DPSCs.
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Establishment of DPSCs from HD monkeys
We have isolated and established DPSCs from the teeth
buds of three double-transgenic HD/G monkeys
(rHD11, rHD17 and rHD18) and one transgenic GFP
monkey (rGFP). rHD17 and rHD18 died shortly after
birth at full term. Both rHD17 and rHD18 demonstrated
HD phenotypes including severe dystonia and chorea
[22]. rHD11 and rGFP were miscarried monkeys, born
at four months of gestation. rHD/G-DPSCs have distinc-
tive morphology including long and spindle shaped (Fig-
ure 1A) which were similar to published reports of
rBMSCs [23], rhesus monkey DPSCs (rDPSCs) [4],
Chimpanzee DPSCs (ChDPSCs) [2], hBMSCs and
hDPSCs [3,24,25]. There were no overt differences in
cellular characteristics of DPSCs derived from different
individuals. All cell lines expressed GFP (Figure 1A) and
were capable of self-renewal.
Expression of stem cell specific transcription factors in
rHD/G-DPSCs
To further evaluate stem cell properties of rHD/G-
DPSCs with various degree of mutant htt, quantitative
measurement of stemness factors (Oct-4, Nanog and
Rex-1; Figure 2) was performed by Q-PCR. There was
no different in the expression pattern of stemness fac-
tors between canine and molar derived DPSCs. How-
ever, variations in expression levels were observed
among individuals (Figure 2). rHD17 and rHD18 have
lower expression compared to rHD11 and rGFP.
Differentiation competence of rHD/GFP-DPSCs
One of the defining characteristics of ASCs is multipo-
tent differentiation capability. All rHD/G-DPSCs were
capable of differentiating into osteogenic (Figure 1B),
adipogenic (Figure 1C) and chondrogenic lineages (Fig-
ure 1D), which are trademark events of ASCs [24,26]
and DPSCs [3,4]. The multipotent differentiation cap-
ability of rHD/G-DPSCs and r/G-DPSCs were similar to
published reports of rhesus macaques [4,23], chimpan-
zee [2] and humans [3,24] ASCs. Similar to previous
studies, the fat droplets in DPSCs were relatively smaller
and less intense than that of BMSCs [2,4].
The effect of mutant htt on the differentiation capacity
of HD-DPSCs was further determined by quantitative
measurement on the expression of lineage specific mar-
kers including osteopontin (osteogenic marker), lipopro-
tein lipase (adipogenic marker) and collagen II
(chondrogenic marker) by Q-PCR (Figure 3). There was
no detectable expression of lipoprotein lipase and col-
lagen II prior to induction. On the other hand, osteopon-
tin was expressed before induction and was increased in
some of the DPSC lines after induction. Variations
among cell lines were also observed (Figure 3).
Cell surface antigen profile
The expression profile of cell surface antigens is another
method for determining the similarity between cell types
and is often used to isolate ASCs. A total of 13 cell sur-
face antigens were examined and compared to published
reports. rHD/G-DPSCs were positive for CD29
+, CD73
+,
CD90
+,C D 1 6 6
+,C D 5 9
+,C D 4 4
+ and CD105
+,a l lo f
which are BMSC markers (Table 1). However, markers
specific for hematopoietic cells, including CD14, CD34,
a n dC D 4 5 ,w e r en o td e t e c t e d( T a b l e1 ) .r H D / G - D P S C s
were also negative for CD18, CD24 and CD150 (Table
1). These results were comparable to the expression
profiles of the rG-DPSCs and other higher primates
(Table 1) [2,4,23,24,27]
Expression of mutant htt in rHD/G-DPSCs
In order to determine the effect of mutant htt on the
properties of rHD/G-DPSCs, the expression of mutant
htt and the formation of oligomeric htt were evaluated.
Expression of mutant htt was significantly increased in
all HD-DPSCs determined by Q-PCR (Figure 4A).
Among HD-DPSC lines, rHD17 had the highest expres-
sion of mutant htt, while rHD11 has the lowest (Figure
4A). The formation of mutant htt aggregate was
revealed by using western blotting analysis (Figure 4B)
and immunostaining (Figure 4C) using mEM48, a
monoclonal antibody that binds to human htt enhanced
with a polyQ expansion. Nuclear inclusions and mutant
htt aggregates were observed in all rHD/G-DPSCs, but
not in rG-DPSCs (Figure 4C). Among the three HD
monkeys, rHD17 had the most extensive intranuclear
inclusions and cytoplasmic mutant htt aggregates com-
p a r e dt or H D 1 1a n dr D H 1 8 .W e s t e r nb l o t t i n ga n a l y s i s
further confirmed the presence of oligomeric htt at a
high molecular weight (> 250 kD) in the upper portion
of a gradient polyacrylamide gel (Figure 4C) in all HD-
DPSC cell lines. Again, rHD17 had a more intense band
than rHD11 and rHD18, suggesting the presence of
more oligomeric htt. The observation of htt by immu-
nostaining of rHD/G-DPSCs was consistent with the
expression level of mutant htt determined by Q-PCR
and the extent of oligomeric htt demonstrated by Wes-
tern blot analysis.
Discussion
Latest advancements in therapeutic applications of ASC
have driven our interest in evaluating a patient’so w n
DPSCs as an alternative source for cell therapy.
Although recent studies have demonstrated the differen-
tiation potential of DPSCs toward neuronal lineage [5,6],
in-depth characterization such as biofunctions in vivo
will further determine the therapeutic potential of DPSC
derived neural cells. While therapeutic applications of
DPSCs in cell replacement therapy are at preliminary
Snyder et al. BMC Cell Biology 2011, 12:39
http://www.biomedcentral.com/1471-2121/12/39
Page 2 of 8Figure 1 Isolation, culture and differentiation of rHD/G-DPSCs. (A) Spindle and fibroblast-like cells were observed in rHD/G-DPSC culture
(Left), rHD/G-DPSCs express GFP (center) and overlay image (right). (B) Osteogenic differentiation, (C) Adipogenic differentiation, and (D)
Chondrogenic differentiation of rHD/G-DPSCs and rG-DPSCs. Osteogenic and adipogenic differentiation were demonstrated by three weeks
induction followed by Alizarin Red S and Oil-Red O staining, respectively. Chondrogenic differentiation was demonstrated by four weeks
induction followed by Alcian blue staining of cryosection.
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and in vivo validation are important steps. Unlike cell
replacement, endogenous stem cells are expected to
divide and differentiate under the influence of the DPSC
graft and the microenvironment [4,5,12].
In this study, HD-DPSCs were derived from teeth
buds of miscarried HD monkeys and HD monkeys that
died soon after birth. While the biofunctions of HD-
DPSCs may vary from those derived from adult indivi-
duals, our findings suggested rHD/G-DPSCs retain
properties comparable to ASCs [3,4,24,27]. Additionally,
the impact of age on the biofunctions of DPSCs has not
been fully addressed and it is important for determining
future applications of DPSCs derived from individuals at
different ages. Although we speculate the biofunctions
of DPSCs will not be impacted significantly by age, the
derivation efficiency of DPSCs may vary due to the
number of stem cells existed in the dental pulps. While
the present study is aimed to determine if DPSCs with
inherited genetic defect retain ASC properties, our
future goal is to determine if DPSCs derived from living
HD monkeys or patients can be used to derive neuronal
Figure 2 Expression of stemness factors. Quantitative analysis of
the transcripts of stemness factors (Oct4, Nanog and Rex1) in
canine and molar of rHD/G-DPSCs and rG-DPSCs was determined
by qRT-PCR. Column shares the same alphabet are significantly
different (P < 0.05). Three replicas were performed.
Figure 3 Expression of differentiation markers.Q u a n t i t a t i v e
analysis of the transcripts of differentiation markers (Osteopontin,
Lipoprotein lipase and Collagen II) in canine and molar of rHD/G-
DPSCs and rG-DPSCs was determined by qRT-PCR. No detectable
expression of lipoprotein lipase and collagen II was observed before
induction of differentiation. Column shares the same alphabet are
significantly different (P < 0.05). Three replicas were performed.
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correction of HD-DPSCs may be considered prior cell
transplantation because HD-DPSCs may not have long-
e v i t ya n dm a yn o tf u n c t i o ni nt h es a m ew a ya sD P S C s
derived from normal animals.
Multipotent differentiation capability was evaluated by
in vitro differentiation into osteogenic, adipogenic and
chondrogenic lineages. Differentiation into these three
lineages is considered one of the basic requirements for
BMSCs, which is widely applied in ASCs [24]. All rHD/
G-DPSCs differentiated to osteogenic, adipogenic and
chondrogenic lineages, which were comparable to rG-
DPSCs and published reports (Figure 1) [2-4,27,28].
Recent studies have suggested that DPSCs are also cap-
able of differentiating into neurons [5,6,8,29]. Although
the current paradigm of ASC therapy is primarily based
on the homing nature of ASCs [12,30,31] and their cap-
ability of eliciting a local repair response [4,12,30,32],
their ability to differentiate into multiple cell types
including neurons may be therapeutically relevant.
While all tested cell lines were capable of differentiating
into three different lineages, quantitative studies on spe-
cific lineage markers suggested variations in differentia-
tion capacity among DPSC cell lines exists. Therefore,
whether DPSCs derived from HD monkeys or normal
rhesus monkeys have more preferred lineages upon dif-
ferentiation cannot be concluded.
Conclusions
O u rr e s u l t ss u g g e s t e dt h a tD P S C sd e r i v e df r o mH D
monkeys retain ASC properties, thus one may consider
that these cells also retain biofunctions comparable to
those derived from healthy individuals [4]. This study
supports the potential future therapeutic application of
DPSCs from patients with genetic disorders such as HD.
We demonstrated that DPSCs from HD monkeys are
comparable in all aspects that define ASCs. Thus DPSCs
derived from patients with inherited genetics diseases
hold great promise as an alternative source for personal
cell therapy.
Methods
All transgenic HD monkeys were housed under the
guideline of the IACUC approved procedures and the
support of the Division of Animal Resources at the
Yerkes National Primate Research Center (YNPRC). All
procedures were approved by YNPRC/Emory Animal
Care and Biosafety Committees.
Generation of transgenic monkeys [22]
Transgenic Huntington’s monkeys were generated as
described by Yang and colleagues [22]. In brief, lenti-
viruses carrying the Exon 1 of the htt gene containing
expanded CAGs under the control of ubiquitin promo-
ter were used to infect metaphase II arrested rhesus
monkey oocytes followed by fertilization and embryo
transfer into surrogate females.
Isolation and culture of DPSCs [4,25]
The teeth germs/buds were recovered from monkeys
miscarried at four months gestation (rHD11 and rGFP)
and died soon after birth (rHD17 and rHD18). The
teeth germs/buds were then digested in 3 mg/ml col-
lagenase type I and 4 mg/ml dispase (Invitrogen, Inc)
for one hour at 37°C. Single cell suspension was filtered
through a 70 μm cell strainer and was then cultured in
Table 1 Cell surface antigen profiles of ASCs derived from monkey, chimpanzee and human
rHD/G-DPSCs rDPSCs hBMSCs ChDPSCs [2] rBMSCs [23] hDPSCs [3] hBMSCs [24]
CD14* - - - - - - -
CD18 - - - - ND ND -
CD24 - - - - ND ND -
CD29 + + + + + + +
CD34* - - - - - - -
CD44 + + + + ND + +
CD45* - - - - - - -
CD59 + + + + ND ND +
CD73* + + + + ND ND +
CD90* + + + + + ND +
CD105* + + + + ND ND +
CD150 - - - - ND - -
CD166 + + + + + + +
*Important markers for hBMSCs
ND-Not Determine
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plemented with 20% FBS (Atlanta Biologicals, Inc), 2
mM glutamine, 100 units/ml penicillin and 100 μg/ml
streptomycin (Invitrogen, Inc.)) at 37°C with 5%CO2.
Adipogenic, osteogenic and chondrogenic differentiation
[2,4,25]
For adipogenic differentiation, cells were seeded at 400
cells/35 mm tissue culture dish and cultured for 11 days
in DPSC medium. On day 11, the medium was supple-
mented with 5.0 μg/ml insulin, 50 μM indomethacin, 1
μM dexamethasone, and 0.5 μMI B M X ,w h i c hw a s
replaced every 3-4 days for a total of three weeks. The
culture was then fixed in 4% paraformaldehyde (PFA)
and stained with 0.0125% Oil-Red-O in isopropanol for
20 minutes at RT followed by a thorough wash and
microscopic examination.
For osteogenic differentiation, cells were prepared as
described for adipogenic differentiation until day 11. On
day 11, the medium was supplemented with 1 nM dexa-
methasone, 50 uM L-Ascorbic acid 2-phosphate sesqui-
magnesium salt, 20 mM b-glycerolphosphate, and 50
ng/ml L-thyroxine sodium pentahydrate, and was
replaced every 3-4 days for a total of three weeks. The
culture was then fixed in 4% PFA and stained with 1%
Alizarin Red S, pH 4.1 for 20 minutes at RT followed by
a thorough wash and microscopic examination.
For chondrogenic differentiation,2 . 5×1 0
5 DPSCs
were centrifuged in a 15 ml conical tube at 1,000 rpm
for five minutes. The pellet was maintained in a DPSC
medium supplemented with ITS-plus premix (BD Bios-
ciences) to a final concentration of 6.25 ug/ml insulin,
6.25 ug/ml transferrin, and 6.25 ng/ml selenious acid.
Additionally, 5.35 ug/ml linoleic acid, 1.25 mg/ml
bovine serum albumin, 50 μg/ml Ascorbate 2-phos-
phate, 40 μg/ml L-proline, 100 μg/ml Sodium pyruvate,
100 nM Dexamethasone, 100 units/ml penicillin, 100
μg/ml streptomycin and 10 ng/ml TGF-b3( R & DS y s -
tems) were also supplemented. Medium was replaced
every 3-4 days for a total of four weeks. The pellets
were then fixed in 4% PFA overnight. The paraffin-
embedded sections (4-5 μm) were stained with 1%
Alcian blue in 10% sulphuric acid solution for 15 min-
utes followed by a thorough wash and microscopic
examination.
Quantitative Real-Time PCR (Q-PCR)
RNA from cell samples was prepared using RNeasy Mini
kit (Qiagen). An equal amount of total RNA was used to
synthesize cDNA followed by Q-PCR using iQ5 Real-
Time PCR Detection System (Bio-Rad). Specific-qPCR
primer sets targeting stem cell and differentiation mar-
kers were used (Additional file 1).
Figure 4 Expression of the mutant htt. (A) Quantitative analysis
of htt transcripts in rHD/G-DPSCs and rG-DPSCs. qRT-PCR was used
to measure the amount of htt transcripts. In addition to measuring
the expression level of exon1, which is composed of both
endogenous htt and the mutant htt, an additional set of primers
measuring the expression level of Exon10/12 was used to show the
level of normal htt alleles. The htt expression was significantly
increased in all rHD-DPSC lines compared to rGFP. Column shares
the same alphabet are significantly different (P < 0.05). (B) Western
analysis demonstrated the accumulation of oligomeric htt (arrow) at
high molecular weight (> 250 kD) that can be clearly seen in upper
portion (Arrow) of a gradient polyacrylamide gel (upper panel).
Antibody to g-tubulin (bottom panel). (C) Subcellular distribution of
mutant htt in rHD/G-DPSCs. DPSCs of rHD11, rHD17, rHD18 and
rGFP were immunostained with mEM48. Transgenic mutant htt
aggregates (arrows) and nuclear inclusions (arrowheads) were only
observed in rHD11, rHD17 and rHD18 but not in DPSCs of rGFP.
Scale bar = 5 μm.
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Cell samples were fixed using 4% PFA, permeabilized
and blocked. The expression of mutant htt was then
incubated with mEM48. The mEM48 (1:200) immunor-
eactive product was visualized with the avidin-biotin
complex kit (Vector ABC Elite). For fluorescent micro-
scopy, the samples were examined with an Olympus
BX51 epifluorescent microscope.
Western Blotting [22]
Total protein was extracted and concentrated for analysis
using the Bradford Assay (Bio-Rad, Inc.). Equal amounts of
the protein were boiled prior to polyacrylamide gel electro-
phoresis, the proteins were transferred onto a PVDF mem-
brane (Millipore Immobion P, Millipore, Inc.) using Bio-
Rad’s transblot. The membrane was then blocked, incu-
bated with primary antibody, secondary antibody, and
detected using Amersham’sE C Lk i t( A m e r s h a m ,I n c . ) .T h e
amount of protein was quantified using a densitometer.
Flow cytometry analysis [2,4]
Cell samples at 2 × 10
5 cells/tube were stained with FITC
or PE-conjugated anti-CD14, -CD45, -CD59, -CD73,
-CD90, -CD150, -CD166, -IgG1k, -IgG2ak (BD Pharmin-
gen), or anti-CD18, -CD24, -CD29, -CD34, -CD44 (BD
Biosciences), or anti-CD105 (eBioscience). After incubat-
ing 20 minutes at RT in the dark, cells were washed with
2 mL FACS wash solution (dPBS+1%BSA+0.1%NaN3)
and centrifuged five minutes at 230 × g. Supernatant was
removed and cells were fixed with 1% formaldehyde. All
data was acquired using a FACS Calibur (Becton Dickin-
son) and analyzed using CellQuest (Becton Dickinson)
and Flowjo software (Treestar, Inc.).
Statistical analysis
Data analyses were carried out using the Student t-test.
Additional material
Additional file 1: Supplemental Methods. Primer sets for stemness and
differentiation markers.
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